Effects of monensin on insulin processing in adipocytes. Evidence that the internalized insulin-receptor complex has

Insights

Monensin, an ionophore, causes insulin accumulation in rat fat cells by preventing its release. This accumulation is ATP-dependent and retains partial insulin signaling capacity for glucose transport and phosphodiesterase activity.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Insulin signaling is crucial for glucose metabolism.
  • Endocytosis and intracellular trafficking regulate insulin receptor activity.
  • Ionophores like monensin can disrupt cellular processes.

Purpose of the Study:

  • To investigate the effect of monensin on insulin accumulation in isolated rat adipocytes.
  • To determine the mechanism behind monensin-induced insulin accumulation.
  • To assess the functional consequences of accumulated insulin-receptor complexes.

Main Methods:

  • Incubation of isolated rat epididymal adipocytes with radiolabeled iodoinsulin and monensin.
  • Measurement of accumulated radioactivity and its characteristics (e.g., TCA precipitation, antibody reactivity).
  • Assessment of cellular glucose transport and cAMP phosphodiesterase activities under various conditions.

Main Results:

  • Monensin (10-100 microM) significantly increased intracellular accumulation of iodoinsulin.
  • Accumulation was ATP-dependent and inhibited insulin dissociation from cells.
  • Accumulated complexes retained partial stimulatory capacity for glucose transport and phosphodiesterase.
  • Chloroquine also induced insulin accumulation but resulted in loss of hormonal effect.

Conclusions:

  • Monensin likely promotes intracellular insulin-receptor complex accumulation by inhibiting endocytic vesicle acidification.
  • The accumulated complexes retain a functional capacity to stimulate key insulin-responsive pathways.
  • These findings offer insights into the regulation of insulin signaling and receptor trafficking.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...